| Literature DB >> 30787188 |
Jasper Mullenders1,2, Evelien de Jongh1,2, Anneta Brousali3,4, Mieke Roosen1,2, Jan P A Blom1,2, Harry Begthel1,2, Jeroen Korving1,2, Trudy Jonges5, Onno Kranenburg3,4, Richard Meijer6, Hans C Clevers7,2.
Abstract
Bladder cancer is a common malignancy that has a relatively poor outcome. Lack of culture models for the bladder epithelium (urothelium) hampers the development of new therapeutics. Here we present a long-term culture system of the normal mouse urothelium and an efficient culture system of human bladder cancer cells. These so-called bladder (cancer) organoids consist of 3D structures of epithelial cells that recapitulate many aspects of the urothelium. Mouse bladder organoids can be cultured efficiently and genetically manipulated with ease, which was exemplified by creating genetic knockouts in the tumor suppressors Trp53 and Stag2. Human bladder cancer organoids can be derived efficiently from both resected tumors and biopsies and cultured and passaged for prolonged periods. We used this feature of human bladder organoids to create a living biobank consisting of bladder cancer organoids derived from 53 patients. Resulting organoids were characterized histologically and functionally. Organoid lines contained both basal and luminal bladder cancer subtypes based on immunohistochemistry and gene expression analysis. Common bladder cancer mutations like TP53 and FGFR3 were found in organoids in the biobank. Finally, we performed limited drug testing on organoids in the bladder cancer biobank.Entities:
Keywords: bladder cancer; organoid; urothelium
Year: 2019 PMID: 30787188 PMCID: PMC6410883 DOI: 10.1073/pnas.1803595116
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205